BC tissues; adjacent normal tissues; tumor tissues
MCF10A; MB231; BT549
cell line-derived xenograft
proliferation (promotes); migration (promotes); invasion (promotes); metastasis (promotes); EMT (promotes); stemness (promotes); glycolysis (promotes); ceRNA regulation (promotes)
Microarray; RT-qPCR; RNase R Treatment; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; Bioinformatics Analysis; Luciferase Reporter Assay; RIP (RNA Immunoprecipitation); RNA Pull-Down; Transfection; CCK8; EdU Staining; Wound Healing Assay; Transwell Assay; Western Blot; In Vivo Animal Model; IHC (Immunohistochemistry)
provided potential target for the treatment of BC
circ_0059457 is up-regulated in breast cancer tissues and cells and promotes malignant progression. Mechanistically, it sponges miR-140-3p to regulate UBE2C, thereby promoting proliferation, migration, invasion, sphere formation, glycolysis, EMT-related changes, and xenograft tumor growth. The study proposes circ_0059457 as a potential therapeutic target for breast cancer.
0.8399
Circ_0059457 Promotes Proliferation, Metastasis, Sphere Formation and Glycolysis in Breast Cancer Cells by Sponging miR-140-3p to Regulate UBE2C.
combined biological and clinical study